Wolf Haldenstein Adler Freeman & Herz LLP is investigating Semler Scientific Inc. (NASDAQ: SMLR) for potential violations of securities laws

Core Viewpoint - Wolf Haldenstein Adler Freeman & Herz LLP is investigating claims on behalf of investors of Semler Scientific Inc. regarding potential securities fraud by the company and its officers and/or directors [1][2]. Investigation Details - The investigation is focused on whether Semler and certain officers and/or directors have engaged in securities fraud [2]. - Semler disclosed in its Form 10-K filed on February 28, 2025, that it received a civil investigative demand from the U.S. Department of Justice (DOJ) in July 2017 concerning claims for reimbursement related to the QuantaFlo device [3]. - The company has received multiple requests for information from the DOJ over the years, with the most recent being in April 2023 [3]. - In February 2025, Semler engaged in unsuccessful settlement discussions with the DOJ, which raises the risk of a potential civil False Claims Act lawsuit seeking damages [3]. Firm Background - Wolf Haldenstein has extensive experience in prosecuting securities class actions and derivative litigation in various courts across the United States [3]. - The firm is recognized for its expertise in shareholder and class litigation, having been appointed to significant positions in complex securities and multi-district litigation by the courts [3].